![Is_The_FDA_Still_Approving_Drugs_During_the_Pandemic[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F603523%2Fis_the_fda_still_approving_drugs_during_the_pandemic1.jpg&w=479&h=281&op=resize)
Is The FDA Still Approving Drugs During the Pandemic?
Multiple drugmakers gained FDA approval last week.
Alnylam Pharmaceuticals
ALNY
ALNY
$166.36
$1.29
0.8%
Price as of January 15, 2021, 9:00 p.m. EST
View Interactive ALNY Charts
A biopharmaceutical company developing novel therapeutics based on RNA interference, which is a naturally occurring biological pathway within cells for selectively silencing and regulating specific genes.
Interactive Chart
News & Analysis: Alnylam Pharmaceuticals
The Fool has written over 200 articles on Alnylam Pharmaceuticals.
3 Reasons Alnylam Is a Top Biotech Stock to Buy Right Now
The company's rare disease treatments are a huge success and there will probably be a lot more of them.
Every Stock Tells a Story
Beyond numbers.
Alnylam Pharmaceuticals Inc (ALNY) Q3 2020 Earnings Call Transcript
ALNY earnings call for the period ending September 30, 2020.
Can Either of These Little-Known Biotechs Find New Life Fighting Coronavirus?
Two small biotechs collaborated to find a coronavirus vaccine, but one of them may come out way ahead due to its expertise and other partnerships.
3 Healthcare Stocks I Can't Wait to Buy When the Stock Market Tanks Again
Get your watch list ready with the best businesses the healthcare sector.
Alnylam Pharmaceuticals Inc (ALNY) Q2 2020 Earnings Call Transcript
ALNY earnings call for the period ending June 30, 2020.
Is Alnylam a Good Biotech Stock to Buy Now?
This biotech could earn its third new drug approval in as many years.
Is Alnylam Pharmaceuticals a Buy?
The stock is up an amazing 2,100% since the company went public, stomping the S&P 500.
Alnylam Pharmaceuticals Inc (ALNY) Q1 2020 Earnings Call Transcript
ALNY earnings call for the period ending March 31, 2020.
